InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,439.60
(
2.13%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
-1.03%
)
Bitcoin
62,794.23
(
6.21%
)
Post# of 251701
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

ilpapa

Send PM Follow Ignore
Followers 6
Posts 1313
Boards Moderated 0
Alias Born 11/02/2003

ilpapa

Re: None

Thursday, 11/13/2014 7:37:19 AM

Thursday, November 13, 2014 7:37:19 AM

Post# of 251701
FT, FWIW

Merck The German drugmaker releases third-quarter earnings today. It agreed to pay $17bn for US pharmaceutical company Sigma-Aldrich in September. The deal indicated that Merck, known for its cancer treatment Erbitux, is shifting away from the drugs market: Sigma-Aldrich is one of the biggest producers of speciality chemicals for research use. (FT)
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up